AI model analyses DNA to identify people at higher risk of stroke - Euronews.com

Hang Liu1, Peng Liu3, Jiawei Yu1, Qiang Lu2, Yerong Qian1, Junxi Xiang1, Aihua Shi4, Shasha Wei4, Yi Lv1,3,4 & … Lifei Yang3,4 We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Jiménez-Gómez has received support for attending meetings and/or travel from Oximesa Nippon Sanso. The other authors have declared no conflicts of interest. Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

The publication of this infographic was funded by Vertex Pharmaceuticals. Medical writing assistance was provided by Bethany Cooper, Ownership Health Limited, UK. Advances in cystic fibrosis care have transformed expectations for many people living with the disease. Evidence continues to support intervening early to prevent irreversible organ damage and optimise outcomes.

David Mannino | Professor, University of Kentucky College of Medicine, Lexington, USA; Chief Medical Officer, COPD Foundation Could you tell us what first drew you to respiratory medicine and COPD, and how this interest has developed throughout your career?